Stryker Corporation (SYK)

Market Cap	135.81B
Revenue (ttm)	24.38B
Net Income (ttm)	2.94B
Shares Out	382.42M
EPS (ttm)	7.61
PE Ratio	46.71
Forward PE	24.53
Dividend	$3.36 (0.95%)
Ex-Dividend Date	Sep 30, 2025

Volume	350,394
Open	354.63
Previous Close	353.81
Day's Range	352.50 - 357.50
52-Week Range	329.16 - 406.19
Beta	0.90
Analysts	Buy
Price Target	434.07 (+22.23%)
Earnings Date	Oct 30, 2025

About SYK

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 53,000
• Stock Exchange: NYSE
• Ticker Symbol: SYK
• Website: https://www.stryker.com

Financial Performance

In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.

Analyst Summary

According to 16 analysts, the average rating for SYK stock is "Buy." The 12-month stock price target is $434.07, which is an increase of 22.23% from the latest price.

Price Target

$434.07

(22.23% upside)

Analyst Consensus: Buy